The specific SOD inhibitor TETA suppressed the activity of antibodies in healthy individuals, starting at a concentration of 2.05 mM, and in patients with schizophrenia, starting at a concentration of 1.85 mM. The gene discussed is SOD1; the disease is schizophrenia.